TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Pierre Fabre Pharma Norden AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
139,769
|
162,323
|
151,103 |
Financial expenses |
232
|
388
|
207 |
Earnings before taxes |
4,271
|
5,383
|
4,217 |
EBITDA |
4,082
|
5,919
|
4,489 |
Total assets |
105,296
|
87,079
|
105,644 |
Current assets |
104,687
|
86,459
|
104,882 |
Current liabilities |
89,050
|
70,200
|
91,355 |
Equity capital |
16,246
|
16,879
|
14,290 |
- share capital |
269
|
267
|
291 |
Employees (average) |
16
|
15
|
14 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
15.4%
|
19.4%
|
13.5% |
Turnover per employee |
8,736
|
10,822
|
10,793 |
Profit as a percentage of turnover |
3.1%
|
3.3%
|
2.8% |
Return on assets (ROA) |
4.3%
|
6.6%
|
4.2% |
Current ratio |
117.6%
|
123.2%
|
114.8% |
Return on equity (ROE) |
26.3%
|
31.9%
|
29.5% |
Change turnover |
-23,389
|
23,459
|
15,063 |
Change turnover % |
-14%
|
17%
|
11% |
Chg. No. of employees |
1
![]() |
1
![]() |
1 |
Chg. No. of employees % |
7%
![]() |
7%
|
8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.